Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 14, 2010; 16(46): 5889-5894
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5889
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5889
Irinotecan-involved regimens for advanced gastric cancer: A pooled-analysis of clinical trials
Dan-Ling Wang, Dong-Ying Gu, Hua-Ying Huang, Zhi Xu, Jin-Fei Chen, Department of Oncology, Affiliated Nanjing First Hospital, Nanjing Medical University, 68 Changle Road and Medical School of Southeast University, 87 Dingjiaqiao, Nanjing 210000, China
Author contributions: Wang DL collected, analyzed, interpreted the data and wrote the manuscript; Gu DY was responsible the technology and materials; Huang HY contributed to the support; Xu Z supervised the study; Chen JF provided the conception and designed and supervised the study.
Supported by Affiliated Nanjing First Hospital, Nanjing Medical University and Medical school of Southeast University
Correspondence to: Dr. Jin-Fei Chen, Department of Oncology, Affiliated Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China. jinfeichen@sohu.com
Telephone: +86-25-87726234 Fax: +86-25-87726234
Received: May 29, 2010
Revised: August 17, 2010
Accepted: August 24, 2010
Published online: December 14, 2010
Revised: August 17, 2010
Accepted: August 24, 2010
Published online: December 14, 2010
Core Tip